# Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)

> **NCT02279654** · — · COMPLETED · sponsor: **Celgene** · enrollment: 389 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT02279654
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-17
- **Primary completion:** 2022-03-29
- **Final completion:** 2022-03-29
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2022-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279654, "Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02279654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*